Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2005-10-28
pubmed:abstractText
This report describes the synthesis of [11C]2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-3(2H)-pyridazinone ([11C]FR194921), a highly selective, nonxanthine-type adenosine A(1) receptor antagonist, used in brain imaging in rats and conscious monkeys as a potential novel PET tracer. [11C]FR194921 was successfully synthesized in 19 min after [11C]CH3I formation. The radiochemical yield was 38+/-3%; and radioactivity was 4.1+/-0.4 GBq, calculated from end of synthesis; radiochemical purity was higher than 99%; and the specific radioactivity was 25.0+/-8.1 GBq micromol(-1) (n=5). In a rat experiment, the distribution of [11C]FR194921 was higher in the hippocampus, striatum and cerebellum regions. This accumulation was significantly decreased by approximately 50% by pretreatment with 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), an adenosine A1 receptor antagonist, which indicated specific binding of the radioligand to adenosine A1 receptors. In conscious monkey PET experiments, [11C]FR194921 accumulated in several regions of the brain, especially in the occipital cortex, thalamus and striatum. These results suggest that [11C]FR194921 can be used as an agent for imaging adenosine A1 receptors in vivo by positron emission tomography (PET).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0969-8051
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
837-44
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16253808-Adenosine A1 Receptor Antagonists, pubmed-meshheading:16253808-Animals, pubmed-meshheading:16253808-Brain, pubmed-meshheading:16253808-Carbon Radioisotopes, pubmed-meshheading:16253808-Male, pubmed-meshheading:16253808-Metabolic Clearance Rate, pubmed-meshheading:16253808-Organ Specificity, pubmed-meshheading:16253808-Piperidines, pubmed-meshheading:16253808-Positron-Emission Tomography, pubmed-meshheading:16253808-Pyridazines, pubmed-meshheading:16253808-Radiopharmaceuticals, pubmed-meshheading:16253808-Rats, pubmed-meshheading:16253808-Rats, Sprague-Dawley, pubmed-meshheading:16253808-Receptor, Adenosine A1, pubmed-meshheading:16253808-Staining and Labeling, pubmed-meshheading:16253808-Tissue Distribution, pubmed-meshheading:16253808-Whole Body Imaging, pubmed-meshheading:16253808-Xanthine
pubmed:year
2005
pubmed:articleTitle
Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
pubmed:affiliation
Basic Research Division, The Medical and Pharmacological Research Center Foundation, Ishikawa 925-0613, Japan. matsuya@mprcf.or.jp
pubmed:publicationType
Journal Article, Evaluation Studies